Navigation Links
Edison Pharmaceuticals Announces Initiation of NIH-Sponsored EPI-743 Clinical Trial with NIH Undiagnosed Diseases Program Patients
Date:9/24/2013

MOUNTAIN VIEW, Calif., Sept. 24, 2013 /PRNewswire/ -- Edison Pharmaceuticals announced today initiation of a phase 2 clinical trial titled "Therapeutic Trial of EPI-743 in Patients with Disorders of Energy Utilization or Oxidation-Reduction."

The trial is a double-blind, placebo-controlled crossover study in which subjects will receive either EPI-743 treatment or placebo for six months. They will then be crossed over to the other arm (treatment or placebo). Eligible subjects must possess defined or undefined genetic diagnoses that feature cellular oxidation/reduction or energy production defects.

Those children absent a genetic diagnosis will be recruited through the National Institutes of Health (NIH) Undiagnosed Diseases Program (UDP). The principle enrollment criterion stipulates that all subjects must have a neuromuscular disorder of suspected mitochondrial or metabolic etiology. All subjects will also be enrolled in a clinical trial studying the natural history of metabolic disorders. Prior to enrollment, patient cells will be analyzed in the laboratory to verify that the cells display biochemical abnormalities associated with mitochondrial disease and can be rescued by EPI-743. 

The primary endpoints in this study are improvement in disease severity and quality of life as measured by the Newcastle Pediatric Mitochondrial Disease Scale. Secondary outcome measures include neuromuscular function and disease-related biochemical markers. More information on study specifics is available on www.ClinicalTrials.gov.

Of the approximately 4 million children born each year in the United States, an estimated 4,000 will have a mitochondrial disease. However, this may be an underestimation of true disease prevalence, since many pediatric neuromuscular patients present with laboratory and clinical findings consistent with energy or mitoc
'/>"/>

SOURCE Edison Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Edison initiates coverage of Derma Sciences
2. Edison expands North American healthcare sector coverage with initiation of coverage on Alexza Pharmaceuticals
3. Edison Expands North American Healthcare Sector Coverage With Initiation of Coverage on Bellus Health
4. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
5. Edison Pharmaceuticals & Bambino Gesu Childrens Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C Deficiency Syndrome Clinical Trial
6. Samsung Medison Showcases New Medical Equipment and Technology with Samsung Electronics at RSNA 2012
7. Edison Pharmaceuticals Closes $20M Series F Financing
8. Edison Pharmaceuticals Announces Initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
9. Massive Hiring Event for Life Science Professionals in Edison, NJ on 9/18/12
10. Edison Pharmaceuticals Announces Positive Results of EPI-743 Phase 2A Leigh Syndrome Clinical Trial
11. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... LOUIS , July 1, 2015 New ... first quarter of 2015 compared to the same time ... the Express Scripts (NASDAQ: ESRX ) Exchange Pulse™ ... first quarter of 2014, the number of new exchange ... declined 18 percent in the first quarter of 2015. ...
(Date:6/30/2015)... EDINBURGH, Scotland , July 1, 2015 ... joins Nu C ana team   ... proprietary ProTide technology to develop and commercialise a portfolio ... Professor Chris McGuigan as Chief Scientific Officer. ... the ProTide technology. He is currently Professor of Medicinal ...
(Date:6/30/2015)... , June 30, 2015 Nortek Security ... NTK ) and a leader in the ... today announced it acquired mobile personal emergency response ... held Numera, Inc. Headquartered in ... easily implemented, mobile PERS products and cloud-based software ...
Breaking Medicine Technology:Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 4
... 2, 2010 Fiscal first quarter revenue from ... $641 million Fiscal first quarter adjusted income from ... $0.87 per share Fiscal first quarter GAAP income ... per share Rx segment revenue grew 47 percent ...
... IRVINE, Calif., Nov. 2, 2010 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today the first clinical implant ... City Hospital in Auckland, New Zealand.  The procedure was ... of Interventional Radiology) and Andrew, Hill, MD (Associate Professor ...
Cached Medicine Technology:Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 2Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 3Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 4Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 5Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 6Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 7Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 8Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 9Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 10Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 11Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 12Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 13Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 14Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 15Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 16Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 17Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 18Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 19Endologix Announces First Clinical Implant of Ventana™ Stent Graft 2Endologix Announces First Clinical Implant of Ventana™ Stent Graft 3Endologix Announces First Clinical Implant of Ventana™ Stent Graft 4
(Date:7/1/2015)... ... July 01, 2015 , ... Bunion Bootie, the newest and ... two or more Bunion Booties directly from their website, http://www.BunionBootie.com can ... misaligned toes and its ultra thin properties allow for protection against rubbing footwear ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... firm B. E. Smith, Tri-City Medical Center in Oceanside, Calif., has ... proven record of leading organization-wide compliance adaptation efforts and growing a focus on ...
(Date:7/1/2015)... ... ... The Recovery Workforce Summit: 2015 PRA Annual Conference , presented by ... as a keynote on June 2nd in Philadelphia, PA. Stossel led a timely keynote ... power and reach to the essential message, while opening doors to wellness and recovery. ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... and the Florida Panhandle, the regional southeast Alabama community health system announced ... clinical communications workflow solution provider. TelmedIQ, a burgeoning leader in secure healthcare ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... cannabis space, created a web-based resource where legal cannabis startups can ... together visionary entrepreneurs and medical marijuana advocates looking to strategically enter and capitalize ...
Breaking Medicine News(10 mins):Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 2Health News:Tri-City Medical Center Hires New Chief Compliance Officer 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 4Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 5Health News:Southeast Alabama Community Health System Chooses TelmedIQ to Meet Secure Text Messaging Challenges for Healthcare 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 3
... of an unfertilized egg or development of eggs from ... On! This is not all. Scientists have ... are made from a single egg, without the need ... parthenotes by taking donated eggs from women who were ...
... it is equally important to lose weight in a healthy ... whole grains and other such nutritious foods// seems tempting isn’t ... is more effective than the conventional diet regime. It is ... plant-based diet has been found to be more effective at ...
... a study by a researcher from University of California, ... are found not in the similarity of the genome ... them. ,Researcher had described genetic differences between the ... that is also expressed in brain cells associated with ...
... as over the counter drug with out medical prescription ... pregnancy. The decision was announced// by the Indian Health ... minister said, "The step has been taken to enable ... sexual exposure, contraceptive accident or forced sex," Dr. Suneeta ...
... the Steno Diabetes Center, Denmark has found that ... //antihypertensive drugs, reduced the chances of developing kidney ... in urine of these patients. ,Diabetes ... to kidney diseases. Supplementation of Spironolactone has found ...
... have died of it in the last three years. Unofficial estimates, ... more than 2,000 full-blown AIDS cases. The increase //in AIDS patients ... ,Jharkand plans to open condom booths in public places ... attempt to open the condom booths will help to educate people ...
Cached Medicine News:Health News:Weight loss accomplished by high carbohydrate, vegan diet 2Health News:Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug 2
...
... QUANTA LiteTM ANA is an enzyme-linked ... of anti-nuclear antibodies (ANA) in human serum. ... in conjunction with clinical findings and other ... of rheumatic diseases such as systemic lupus ...
... Immuno Concepts manufactures slides that are ... technologist to decrease the number of pipetting ... patient sample dilutions on the slides. Ask ... procedure and these slides. These slide formats ...
... The ANA and ENA assays can ... negative for antinuclear antibodies, which are ... such as Systemic lupus erythematosus (Lupus), ... progressive systemic sclerosis, scleroderma, polymyositis, dermatomyositis, ...
Medicine Products: